EGFR and non-small cell lung carcinoma: As compared to healthy donors, the blood of NSCLC patients was also much more enriched in non‐mutated EGFR copies (Fig. 1C and Fig. S2B), possibly correlating with the presence of tumor‐derived EVs or vesicles deriving from other cells with an ‘altered/activated’ metabolism.